This prospective, single-center, interventional post-market clinical follow-up (PMCF) study aims to evaluate the early-term (24 months post-implantation) safety and efficacy of CE-marked BIODENTOSS® and DWC ® Dental Implants and Superstructures in patients requiring dental restoration for tooth loss.
18 years of age or older,
Male or female,
Subjects with missing tooth who require dental implant treatment,
At least 2 months elapsed since tooth extraction,
Suspected or confirmed pregnancy or breastfeeding,
Disorders preventing adequate daily oral hygiene,
Hypersensitivity/allergy to titanium or implant components,
Inappropriate interarch relationship or parafunction (e.g., bruxism),